BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 21750976)

  • 21. Hepatitis C virus NS2 protein is phosphorylated by the protein kinase CK2 and targeted for degradation to the proteasome.
    Franck N; Le Seyec J; Guguen-Guillouzo C; Erdtmann L
    J Virol; 2005 Mar; 79(5):2700-8. PubMed ID: 15708989
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced binding of RNAP II CTD phosphatase FCP1 to RAP74 following CK2 phosphorylation.
    Abbott KL; Renfrow MB; Chalmers MJ; Nguyen BD; Marshall AG; Legault P; Omichinski JG
    Biochemistry; 2005 Mar; 44(8):2732-45. PubMed ID: 15723518
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protein kinase CK2 inhibitor 4,5,6,7-tetrabromobenzotriazole (TBB) induces apoptosis and caspase-dependent degradation of haematopoietic lineage cell-specific protein 1 (HS1) in Jurkat cells.
    Ruzzene M; Penzo D; Pinna LA
    Biochem J; 2002 May; 364(Pt 1):41-7. PubMed ID: 11988074
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The regulatory beta subunit of protein kinase CK2 contributes to the recognition of the substrate consensus sequence. A study with an eIF2 beta-derived peptide.
    Poletto G; Vilardell J; Marin O; Pagano MA; Cozza G; Sarno S; Falqués A; Itarte E; Pinna LA; Meggio F
    Biochemistry; 2008 Aug; 47(32):8317-25. PubMed ID: 18636746
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CK2 is the regulator of SIRT1 substrate-binding affinity, deacetylase activity and cellular response to DNA-damage.
    Kang H; Jung JW; Kim MK; Chung JH
    PLoS One; 2009 Aug; 4(8):e6611. PubMed ID: 19680552
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phosphorylation of apoptosis repressor with caspase recruitment domain by protein kinase CK2 contributes to chemotherapy resistance by inhibiting doxorubicin induced apoptosis.
    Wang J; Feng C; He Y; Ding W; Sheng J; Arshad M; Zhang X; Li P
    Oncotarget; 2015 Sep; 6(29):27700-13. PubMed ID: 26172393
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phosphorylation by protein kinase CK2: a signaling switch for the caspase-inhibiting protein ARC.
    Li PF; Li J; Müller EC; Otto A; Dietz R; von Harsdorf R
    Mol Cell; 2002 Aug; 10(2):247-58. PubMed ID: 12191471
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Yeast Protein Asf1 Possesses Modulating Activity towards Protein Kinase CK2.
    Baier A; Szyszka R; Jach ME
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555405
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phosphorylation of synthetic fragments of inhibitor-2 of protein phosphatase-1 by casein kinase-1 and -2. Evidence that phosphorylated residues are not strictly required for efficient targeting by casein kinase-1.
    Marin O; Meggio F; Sarno S; Andretta M; Pinna LA
    Eur J Biochem; 1994 Jul; 223(2):647-53. PubMed ID: 8055935
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protein kinase CK2: a newcomer in the 'druggable kinome'.
    Pagano MA; Cesaro L; Meggio F; Pinna LA
    Biochem Soc Trans; 2006 Dec; 34(Pt 6):1303-6. PubMed ID: 17073807
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The importance of negative determinants as modulators of CK2 targeting. The lesson of Akt2 S131.
    Vilardell J; Girardi C; Marin O; Cozza G; Pinna LA; Ruzzene M
    PLoS One; 2018; 13(3):e0193479. PubMed ID: 29494643
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of protein kinase CK2 on inhibitor of apoptosis proteins in prostate cancer cells.
    Wang G; Ahmad KA; Harris NH; Ahmed K
    Mol Cell Biochem; 2008 Sep; 316(1-2):91-7. PubMed ID: 18574673
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular Pathways: Emergence of Protein Kinase CK2 (CSNK2) as a Potential Target to Inhibit Survival and DNA Damage Response and Repair Pathways in Cancer Cells.
    Rabalski AJ; Gyenis L; Litchfield DW
    Clin Cancer Res; 2016 Jun; 22(12):2840-7. PubMed ID: 27306791
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Specific proteolysis of the A-kinase-anchoring protein 149 at the Asp582 residue by caspases during apoptosis.
    Yoo H; Cha HJ; Lee J; Yu EO; Bae S; Jung JH; Sohn I; Lee SJ; Yang KH; Woo SH; Seo SK; Park IC; Kim CS; Jin YW; Ahn SK
    Oncol Rep; 2008 Jun; 19(6):1577-82. PubMed ID: 18497968
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential phosphorylation of Akt1 and Akt2 by protein kinase CK2 may account for isoform specific functions.
    Girardi C; James P; Zanin S; Pinna LA; Ruzzene M
    Biochim Biophys Acta; 2014 Sep; 1843(9):1865-74. PubMed ID: 24769357
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Programmed cell death protein 5 (PDCD5) is phosphorylated by CK2 in vitro and in 293T cells.
    Salvi M; Xu D; Chen Y; Cabrelle A; Sarno S; Pinna LA
    Biochem Biophys Res Commun; 2009 Sep; 387(3):606-10. PubMed ID: 19616514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CK2 phosphorylation of C/EBPδ regulates its transcription factor activity.
    Schwind L; Zimmer AD; Götz C; Montenarh M
    Int J Biochem Cell Biol; 2015 Apr; 61():81-9. PubMed ID: 25680545
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overlapping cleavage motif selectivity of caspases: implications for analysis of apoptotic pathways.
    McStay GP; Salvesen GS; Green DR
    Cell Death Differ; 2008 Feb; 15(2):322-31. PubMed ID: 17975551
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phosphorylation and regulation of a G protein-coupled receptor by protein kinase CK2.
    Torrecilla I; Spragg EJ; Poulin B; McWilliams PJ; Mistry SC; Blaukat A; Tobin AB
    J Cell Biol; 2007 Apr; 177(1):127-37. PubMed ID: 17403928
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A "SYDE" effect of hierarchical phosphorylation: possible relevance to the cystic fibrosis basic defect.
    Venerando A; Cesaro L; Marin O; Donella-Deana A; Pinna LA
    Cell Mol Life Sci; 2014 Jun; 71(12):2193-6. PubMed ID: 24566881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.